Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX1XOF
|
||||
Drug Name |
2-(4-chloro-6-(3-phenylpropylamino)pyrimidin-2-ylthio)-2-(naphthalen-1-yl)acetic acid
|
||||
Synonyms |
CHEMBL1089826
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C25H22ClN3O2S
|
||||
Canonical SMILES |
OC(=O)C(Sc1nc(Cl)cc(NCCCc2ccccc2)n1)c3cccc4ccccc34
|
||||
InChI |
InChI=1S/C25H22ClN3O2S/c26-21-16-22(27-15-7-10-17-8-2-1-3-9-17)29-25(28-21)32-23(24(30)31)20-14-6-12-18-11-4-5-13-19(18)20/h1-6,8-9,11-14,16,23H,7,10,15H2,(H,30,31)(H,27,28,29)
|
||||
InChIKey |
MTEBXMPXGZSGGW-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Peroxisome proliferator activated receptor gamma | Target Info | [1587926] | ||
Arachidonate 5-lipoxygenase | Target Info | [1587926] | |||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
WikiPathways | Wnt Signaling Pathway Netpath | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Differentiation of white and brown adipocyte | |||||
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
Transcriptional Regulation of White Adipocyte Differentiation | |||||
Adipogenesis | |||||
SREBP signalling | |||||
Nuclear ReceptorsWP2877:Vitamin D Receptor Pathway | |||||
Arachidonic acid metabolism | |||||
Eicosanoid Synthesis | |||||
Selenium Micronutrient Network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.